3 / 3
Page 12
47
th
WORLD CONGRESS ON NURSING CARE
11
th
WORLD HEMATOLOGY AND ONCOLOGY CONGRESS
July 24-25, 2019 | Rome, Italy
&
Volume 2
World Hematology 2019 & Nursing Care 2019
July 24-25, 2019
Journal of Blood Disorders and Treatment
J Blood Disord Treat, Volume 2
Prabu Pandurangan
Apollo Hospitals, India
Acquired amegakaryocytic thrombocytopenic purpura with literature review
A
cquired amegakaryocytic thrombocytopenic purpura (AATP) is an uncommon disorder with thrombocytopenia and
selectively suppressed megakaryopoiesis, often mistaken as immune thrombocytopenic purpura (ITP). It usually
does not respond to steroids, and bone marrow examination shows complete absence of megakaryocytes. The treatment
and prognosis of AATP vary greatly from ITP; therefore, it is important to diagnose and treat this condition early, as it can
progress rapidly to complete bone marrow failure. In this case report, we report a patient with AATP responded well to
cyclosporine therapy.
Biography
Pandurangan Prabu had completed his MBBS in the year 1992 and had completed his training in Hematology in May 2006. He was a con-
sultant haematologist from 2006 to 2010 at UK. Currently, he is a senior consultant haematologist at Apollo Hospitals, India. His main area of
work includes the diagnosis and management of haematological malignancies and bleeding disorders. He holds his expertise in autologous
and allogeneic haematopoietic stem cell transplantation.
drprabu.p@gmail.com